Fulgent launches PCR test to detect monkeypox August 4, 2022 -- Fulgent Genetics on Thursday announced it has launched a PCR test that leverages the U.S. Centers for Disease Control and Prevention’s orthopoxvirus test, which detects non-smallpox related orthopoxviruses, including monkeypox.Read More
FDA grants EUA for Qorvo COVID-19 antigen test August 4, 2022 -- Qorvo announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Omnia SARS-CoV-2 Antigen Test in point-of-care settings.Read More
Decline in COVID tests pulls down Q3 revenue at Siemens Healthineers August 3, 2022 -- A sharp decline in revenues from rapid COVID-19 antigen tests contributed to a decline of almost 6% in revenues for the third fiscal quarter at Siemens Healthineers. The company reported "solid" growth from its imaging and radiation oncology businesses.Read More
Exact Sciences Q2 revenues rise 20% August 3, 2022 -- Exact Sciences on Tuesday reported a 20% year-over-year increase in second quarter revenues. For the quarter ended June 30, the firm posted revenues of $521.6 million compared to $434.8 million in Q2 2021.Read More
Veracyte Q2 revenues rise 32% August 3, 2022 -- Veracyte on Tuesday reported second quarter (end-June 30) total revenues of $72.9 million, an increase of 32% compared to $55.1 million in Q2 2021.Read More
Bio-Rad acquires Curiosity Diagnostics for $170M August 3, 2022 -- Bio-Rad Laboratories said Wednesday that it is acquiring Curiosity Diagnostics from Scope Fluidics, a Warsaw, Poland-based developer of molecular diagnostic tests, for up to $170 million.Read More
Talis Biomedical posts 600K in Q2 revenues August 3, 2022 -- Point-of-care testing firm Talis Biomedical on Tuesday reported an uptick in revenue and a decrease in net loss for the second quarter of 2022.Read More